Scott D. Grimes Sells 4,098 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) Director Scott D. Grimes sold 4,098 shares of the stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $50.09, for a total transaction of $205,268.82. Following the sale, the director now directly owns 243,606 shares in the company, valued at $12,202,224.54. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Cardlytics stock traded down $5.52 during midday trading on Thursday, reaching $40.95. The company had a trading volume of 685,626 shares, compared to its average volume of 382,388. The company has a market capitalization of $1.38 billion, a P/E ratio of -10.29 and a beta of 2.32. Cardlytics, Inc. has a 12-month low of $39.07 and a 12-month high of $145.00. The firm’s fifty day simple moving average is $54.91 and its 200-day simple moving average is $66.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.10 and a quick ratio of 1.10.

Cardlytics (NASDAQ:CDLX – Get Rating) last issued its quarterly earnings results on Tuesday, March 1st. The company reported ($0.15) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.76) by $0.61. The firm had revenue of $90.05 million for the quarter, compared to analyst estimates of $76.59 million. Cardlytics had a negative net margin of 48.13% and a negative return on equity of 12.16%. Cardlytics’s quarterly revenue was up 34.2% compared to the same quarter last year. During the same period last year, the company posted ($0.32) EPS. On average, analysts expect that Cardlytics, Inc. will post -3.64 EPS for the current fiscal year.

CDLX has been the topic of several recent analyst reports. Craig Hallum lowered their target price on shares of Cardlytics from $100.00 to $70.00 in a research note on Wednesday, March 2nd. Wells Fargo & Company initiated coverage on shares of Cardlytics in a research note on Tuesday, April 5th. They set an “overweight” rating and a $72.00 target price on the stock. Needham & Company LLC lowered their target price on shares of Cardlytics from $120.00 to $85.00 and set a “buy” rating on the stock in a research note on Wednesday, March 2nd. Finally, Zacks Investment Research raised shares of Cardlytics from a “sell” rating to a “hold” rating in a research note on Tuesday, January 4th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Cardlytics presently has an average rating of “Buy” and an average target price of $83.00.

Hedge funds have recently added to or reduced their stakes in the business. Dark Forest Capital Management LP acquired a new stake in Cardlytics in the 3rd quarter valued at about $39,000. Rockefeller Capital Management L.P. raised its holdings in Cardlytics by 1.5% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 194,229 shares of the company’s stock valued at $16,303,000 after acquiring an additional 2,938 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in Cardlytics by 98.3% in the 4th quarter. Russell Investments Group Ltd. now owns 70,803 shares of the company’s stock valued at $4,677,000 after acquiring an additional 35,099 shares during the last quarter. Baillie Gifford & Co. raised its holdings in Cardlytics by 23.1% in the 4th quarter. Baillie Gifford & Co. now owns 917,876 shares of the company’s stock valued at $60,662,000 after acquiring an additional 172,072 shares during the last quarter. Finally, Jump Financial LLC raised its holdings in Cardlytics by 151.8% in the 3rd quarter. Jump Financial LLC now owns 26,436 shares of the company’s stock valued at $2,219,000 after acquiring an additional 15,936 shares during the last quarter. Institutional investors own 96.44% of the company’s stock.

About Cardlytics (Get Rating)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles